Skip to NavigationSkip to content

Top Ten most popular articles on Pharmafile.com this week

Published on 05/05/17 at 12:08pm

It's Friday again, and today marks the press date of the latest edition of Pharmafile, our bi-annual life sciences market intelligence report - you can read it in print and online next week!

The UK general election and Brexit have been hot topics within the industry: the Institution of Mechanical Engineers this week called for the government to prioritise the $17 billion medtech industry in the face of Britain's exit from the EU, and European Commission has warned that marketing authorisations for drug products could be disrupted in the coming transitionary years.

It has also been a great week for treatment developments and drug access, with new insight into how cancer metastases develop, and the NICE recommendation of Janssen's Crohn's drug Stelara.

Check out the week's ten most popular articles on Pharmafile.com now!

Blood test able to detect cancer a year in advance

A team at the Francis Crick Institute, based in London, has discovered a new way of analysing blood in patients who had previously suffered from cancer to determine whether there was a possibility of recurrence. In one patient, it was found to detect the return of cancer a year prior to a CT scan showing the return of the cancer.

NICE recommends Janssen's first-of-its-kind Crohn's drug Stelara

Janssen has announced that it has secured recommendation from NICE for Stelara (ustekinumab) in the indication of moderately to severely active Crohn’s disease in adults who have proved unresponsive to conventional therapy or a TNFα inhibitor.

Real-world data: High on the life science agenda

John Wise of The Pistoia Alliance discusses the necessity of real-world data for a prosperous future for the life sciences industry, from encouraging collaboration to redefining drug valuation.

UK must prioritise $17bn medtech sector in face of Brexit, new report urges

A new report from the Institution of Mechanical Engineers (IME) has highlighted the threat Brexit poses to the UK medical technology sector, calling on industry to keep pace with EU regulation and funding in order to maintain jobs and investment.

The five competencies of continuous regulatory compliance

Look at any country or region with a strong generic pharmaceutical and active ingredient manufacturing sector, and you are sure to see a diverse industry with business models that range across a spectrum.

Teva has another high profile role to fill

Teva’s gaps at the top level of its structure continue to build, as Eyal Desheh, CFO of the company since 2008, is set to leave his role.

FDA approves first new drug for liver cancer in decade

The FDA has announced that it has approved the first new treatment for hepatocellular carcinoma (HCC), a type of liver cancer, since the approval of sorafenib in 2007.

Study discovers origin of cancer metastases and why they reoccur

A team of scientists from The Scripps Research Institute (TSRI) have discovered the secrets of where metastases originate and why certain cancers resurge even after years in remission.

European Commission warns UK over drug authorisation validity due to Brexit

The European Commission has issued a warning to pharmaceutical firms in the UK that current and future drug authorisations could be disrupted in the wake of Brexit.

Shire creates 150 jobs with Dublin HQ relocation

Rare disease specialist Shire has opened the doors of its new headquarters in Dublin, Ireland. The pharma company has leased 76,000sqft of space at Miesian Plaza in Baggot Street, relocating from its previous home in Citywest.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches